Novartis chips in $10M for IPO-bound partner Pliant; Tenax shares soar on heart drug data
→ Novartis is coming in with $10 million to help support the looming IPO of a partner. Pliant Therapeutics posted a new filing with the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
